Picardi M, Giordano C. Comment on “Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study.”. haematol [Internet]. 2021Apr.1 [cited 2024Apr.19];106(4):1226-7. Available from: https://haematologica.org/article/view/10223